These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10740627)

  • 1. [New combination therapies for gastrointestinal cancer].
    Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takeda N
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):348-55. PubMed ID: 10740627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in chemotherapy for colorectal cancer].
    Sasaki T; Maeda Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [State of the treatment for gastrointestinal cancer].
    Baba H; Kohnoe S; Endo K; Ikeda Y; Toh Y; Nakashima H; Okamura T
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1233-46. PubMed ID: 10945022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
    Sasaki T; Maeda Y; Kobayashi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress of chemotherapy for colorectal cancer].
    Ishiguro A; Shitara K; Munakata M; Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2017-23. PubMed ID: 16352922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy for gastric cancer including LV/5-FU].
    Sasaki T; Maeda Y; Kandaba-shi K; Ono M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
    Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE
    J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer].
    Goto A
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New anti-cancer drugs for gastrointestinal cancers].
    Sasaki T
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1925-31. PubMed ID: 9350237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Second-line chemotherapy for advanced colorectal cancer].
    Uetake H; Iida S; Tsunozaki H; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):24-7. PubMed ID: 15675577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer.
    Yoshimatsu K; Yokomizo H; Fujimoto T; Umehara A; Otani T; Matsumoto A; Osawa G; Shiozawa S; Katsube T; Naritaka Y; Ogawa K
    Anticancer Res; 2007; 27(3B):1641-4. PubMed ID: 17595789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer.
    Tsavaris N; Kosmas C; Gennatas K; Vadiaka M; Skopelitis E; Xila V; Rokana S; Margaris E; Zografos G; Papastratis G; Kouraklis G
    J Chemother; 2002 Aug; 14(4):406-11. PubMed ID: 12420860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of chemotherapy for outpatients with gastric or colorectal cancer].
    Gotoh M; Kawabe S; Takiuchi H; Ohta S; Katsu K
    Gan To Kagaku Ryoho; 2002 Dec; 29 Suppl 3():470-4. PubMed ID: 12536832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
    Uemura N; Yamada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Latest progress on chemotherapy for advanced gastric cancer].
    Tahara M; Ohtsu A
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2048-58. PubMed ID: 11103236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in the treatment of gastric cancer in Europe.
    Köhne CH; Wils JA; Wilke HJ
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):22-5. PubMed ID: 11200144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.